Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00438906 · ClinicalTrials.gov registry record
Cancer of the Pancreas Screening Study (CAPS 3)
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 200
- Enrollment target
NCT00438906: Completed study, sponsored by Johns Hopkins University.
NCT00438906 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00438906 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to find the best and most sensitive screening modality (CT, MRI, EUS)for very small pre-cancerous pancreatic lesions and to treat these small lesions before they turn into cancer. Another purpose of this study is to search for common markers on DNA that would increase the chance of someone developing pancreatic cancer, and locate proteins in pancreatic juice that indicate tumor development.
Primary Outcome
To determine the diagnostic yield of screening high risk patients (defined as relatives of patients with familial pancreatic cancer,patients with familial Peutz-Jeghers syndrome, and patients with germline BRCA2 and p16 mutations) for early pancreatic neoplasia using endoscopic ultrasonography, CT, and MRI/MRCP.
Interventions
- DRUG Secretin (human synthetic) - ChiRhoClin
- PROCEDURE Biopsy, Fine Needle Aspiration (FNA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-12 |
| Est. Completion | 2009-12 |
What the finished NCT00438906 record still lists
NCT00438906 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Secretin (human synthetic) - ChiRhoClin is the first listed.
NCT00438906 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00438906 about?
NCT00438906 is a clinical study titled "Cancer of the Pancreas Screening Study (CAPS 3)". The purpose of this study is to find the best and most sensitive screening modality (CT, MRI, EUS)for very small pre-cancerous pancreatic lesions and to treat these small lesions before they turn into cancer. Another purpose of this study is to search for common markers on DNA that would increase th...
What is the current status of trial NCT00438906?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2006-12. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00438906?
The interventions under investigation include: Secretin (human synthetic) - ChiRhoClin (DRUG), Biopsy, Fine Needle Aspiration (FNA) (PROCEDURE).
Who is sponsoring clinical trial NCT00438906?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia